Home › NDC Lookup › RxCUI directory › RxCUI 835925

Cyclosporine, modified 50 MG Oral Capsule — RxCUI 835925

RxNorm drug concept · Semantic clinical drug
RxCUI 835925 Semantic clinical drug · SCD ● Current RxNorm concept 11 FDA products 11 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI835925
Official nameCyclosporine, modified 50 MG Oral Capsule
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped11
Package NDCs mapped11
Reported Medicaid activity (SDUD)20,395 prescriptions · 42 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Cyclosporine: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Cyclosporine levels in your blood can vary quite a bit, and both too much and too little can cause real problems — too high raises the risk of kidney damage, and too low means the...
  • Why do I need blood tests so often while taking cyclosporine?
  • No — grapefruit and grapefruit juice are a hard no with cyclosporine. They block a key enzyme in your body that normally clears cyclosporine, which can cause your blood levels to c...
  • Can I eat grapefruit while taking cyclosporine?
📖 Read our full Cyclosporine guide →

🕸️ Concept Web — How Cyclosporine, modified 50 MG Oral Capsule Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Cyclosporine, modified 50 MG Oral Capsule RxCUI 835925

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Cyclosporine 3008
    • Cyclosporine, modified 236077
  2. Brand names 2

    The same medicine's trade names. A brand name alone says nothing about strength or form.

    • Atopica 539497
    • Sporimune 2665975
  3. Dose forms 17

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Cyclosporine Oral Capsule 371666
    • Cyclosporine, modified Oral Capsule 2645340
    • Cyclosporine Oral Product 1156189
    • Cyclosporine Pill 1156190
    • Cyclosporine, modified Oral Product 2660112
    • Cyclosporine, modified Pill 2662711
    • Cyclosporine Oral Capsule [Atopica] 539499
    • Cyclosporine Oral Capsule [Sporimune] 2665979
    • +9 more in this family
  4. Clinical & branded drugs 5

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Cyclosporine, modified 50 MG 835924
    • Cyclosporine, modified 50 MG Oral Capsule [Atopica] 835927
    • Cyclosporine, modified 50 MG Oral Capsule [Sporimune] 2665985
    • Cyclosporine, modified 50 MG [Atopica] 835926
    • Cyclosporine, modified 50 MG [Sporimune] 2665984

Showing up to 8 concepts per family — 17 of 26 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Cyclosporine, modified 50 MG SCDC · 835924
  • Cyclosporine Oral Capsule SCDF · 371666
  • Cyclosporine, modified Oral Capsule SCDFP · 2645340
  • Cyclosporine Oral Product SCDG · 1156189
  • Cyclosporine Pill SCDG · 1156190
  • Cyclosporine, modified Oral Product SCDGP · 2660112
  • Cyclosporine, modified Pill SCDGP · 2662711

Brand-Name Concepts

  • Cyclosporine, modified 50 MG Oral Capsule [Atopica] SBD · 835927
  • Cyclosporine, modified 50 MG Oral Capsule [Sporimune] SBD · 2665985
  • Cyclosporine, modified 50 MG [Atopica] SBDC · 835926
  • Cyclosporine, modified 50 MG [Sporimune] SBDC · 2665984
  • Cyclosporine Oral Capsule [Atopica] SBDF · 539499
  • Cyclosporine Oral Capsule [Sporimune] SBDF · 2665979
  • Cyclosporine, modified Oral Capsule [Atopica] SBDFP · 2654174
  • Cyclosporine, modified Oral Capsule [Sporimune] SBDFP · 2665980
  • Atopica Oral Product SBDG · 1172882
  • Atopica Pill SBDG · 1172883

📦 FDA Products & Package NDCs

11 products · 11 package NDCs
11 package NDCs map to RxCUI 835925 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00074-3108-32 3 BLISTER PACK in 1 CARTON (0074-3108-32) / 10 CAPSULE in 1... Gengraf AbbVie Inc. 2015-11-01
00074-3109-32 5 BLISTER PACK in 1 CARTON (0074-3109-32) / 6 CAPSULE in 1... Gengraf AbbVie Inc. 2015-11-01
00093-9018-65 30 BLISTER PACK in 1 CARTON (0093-9018-65) / 1 CAPSULE, LIQ... Cyclosporine Modified Teva Pharmaceuticals USA, Inc. 2021-06-08
00093-9019-65 30 BLISTER PACK in 1 CARTON (0093-9019-65) / 1 CAPSULE, LIQ... Cyclosporine Modified Teva Pharmaceuticals USA, Inc. 2021-06-08
00093-9020-65 30 BLISTER PACK in 1 CARTON (0093-9020-65) / 1 CAPSULE, LIQ... Cyclosporine Modified Teva Pharmaceuticals USA, Inc. 2021-06-08
23155-0837-30 3 BLISTER PACK in 1 CARTON (23155-837-30) / 10 CAPSULE, LIQ... CYCLOSPORINE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2022-11-30
23155-0838-30 6 BLISTER PACK in 1 CARTON (23155-838-30) / 5 CAPSULE, LIQU... CYCLOSPORINE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2022-11-30
23155-0839-30 5 BLISTER PACK in 1 CARTON (23155-839-30) / 6 CAPSULE, LIQU... CYCLOSPORINE Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. 2022-11-30
60505-4630-03 30 BLISTER PACK in 1 CARTON (60505-4630-3) / 10 CAPSULE, LI... CycloSPORINE, Modfied Apotex Corp. 2019-11-05
60505-4631-03 30 BLISTER PACK in 1 CARTON (60505-4631-3) / 5 CAPSULE, LIQ... CycloSPORINE, Modfied Apotex Corp. 2019-11-05
60505-4632-03 30 BLISTER PACK in 1 CARTON (60505-4632-3) / 6 CAPSULE, LIQ... CycloSPORINE, Modfied Apotex Corp. 2019-11-05
Observed labelers: Apotex Corp. (3) · Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. (3) · Teva Pharmaceuticals USA, Inc. (3) · AbbVie Inc. (2) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🧾 Billing Codes (HCPCS)

Medical billing codes (HCPCS "J-codes") that connect to this concept's packages — used mostly when a clinic or hospital bills for a drug it administers. Each code links to its full billing page.
CodeDescriptorMapped packagesSources
J7502 Cyclosporine oral 100 mg 6 CMS
J7515 Cyclosporine oral 25 mg 6 CMS
⚠ A crosswalk is not coverage: an NDC↔HCPCS mapping does not guarantee any payer covers or pays the code. Always verify the current payer policy before billing.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.